WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
-11.22%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$2.19B
AUM Growth
+$2.19B
(-6.1%)
Cap. Flow
+$262M
Cap. Flow
% of AUM
11.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
4
Reduced
1
Closed
–
Top Buys
| 1 |
AbbVie
ABBV
|
$130M |
| 2 |
Prothena Corp
PRTA
|
$120M |
| 3 |
Alkermes
ALKS
|
$54.6M |
| 4 |
Theravance Biopharma
TBPH
|
$33.1M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$74.9M |
Sector Composition
| 1 | Healthcare | 65.08% |
| 2 | Consumer Staples | 34.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAI
1
DELISTED
Reynolds American Inc
RAI
| $765M | 34.92% | 15,196,113 -1,488,477 | -9% | -$74.9M |
|
|
2
AbbVie
ABBV
$372B
| $632M | 28.87% | 11,063,300 +2,269,300 | +26% | +$130M |
|
|
3
Prothena Corp
PRTA
$441M
| $383M | 17.48% | 9,296,361 +2,916,700 | +46% | +$120M |
|
|
4
Alkermes
ALKS
$4.78B
| $244M | 11.14% | 7,131,533 +1,595,964 | +29% | +$54.6M |
|
|
5
Theravance Biopharma
TBPH
$699M
| $128M | 5.86% | 6,824,637 +1,763,000 | +35% | +$33.1M |
|
|
NWBO
6
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $37.8M | 1.73% | 25,915,937 | – | – |
|